Our results show that the investigated CYP2D6 polymorphisms are not a decisive factor in the response to paroxetine and venlafaxine treatment in OCD in spite of their highly significant effect on the blood levels of these medicines.
← all excerpts
Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.
1
—
—